SHL Group to exhibit at Pharmapack 2018

Press Release 201801 Pharmapack2018

SHL Group will participate in Pharmapack 2018, Europe’s dedicated pharmaceutical packaging and drug delivery event, in Paris, France from February 7-8, 2018.

SHL’s booth will highlight devices designed to broaden the potential of next-generation protein-based therapies. Offerings in this space include solutions for higher viscosity drug preparations: the Bertha®, an autoinjector that features a continuous clicking mechanism to enhance usability and safety, and the Rotaject®, a cutting-edge constant force technology that allows for the delivery of highly viscous formulations of up to several hundred centipoise. SHL is also showing a range of higher-volume cartridge-based injectors made with Needle Isolation Technology (NIT®), which helps prevent metal leachables from contaminating the drug product.

Another focus will be SHL’s initiatives in connected therapeutics, such as FlexRec™, a smart packing solution for multi-medication tracking, and InsulCheck®, a smart accessory that clips to an insulin pen and automatically starts counting the time since the last injection. Visitors are invited to step into an augmented reality experience to explore smart injector concepts created by QuiO, SHL’s new partner in innovation.

“Over the last few years, digital healthcare has come into sharp focus for SHL’s research and development, as it represents a truly new frontier for patient-centered healthcare. We have some exciting initiatives underway for connected devices that could go a long way toward solving several of today’s challenges within self-treatment,” said Magnus Fastmarken, global marketing director of SHL Group.

In addition, representatives will be available to talk about SHL’s turnkey solution, which unites SHL’s wide range of development, manufacturing, and commercialization capabilities. At a dedicated site in Florida, we offer final assembly, labeling, and packaging services to streamline the production and distribution process for SHL Medical products, optimizing end-product quality and speed to market.

The two-day conference will be held February 7-8 at the Paris Expo, Porte de Versailles. Visit SHL at Booth D18 to learn more about our advanced drug delivery systems and comprehensive suite of services and capabilities.

About SHL

SHL Group is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit

Media contact:


Related News